Journal of Parasitic Diseases

, Volume 39, Issue 1, pp 18–21

In vitro antileishmanial activity of methanolic and aqueous extracts of Eucalyptus camaldulensis against Leishmania major

  • Seyyed Jafar Nosratabadi
  • Iraj Sharifi
  • Fariba Sharififar
  • Mehdi Bamorovat
  • Hamid Daneshvar
  • Mohammad Mirzaie
Original Article

Abstract

Pentavalent antimony compounds are expensive, toxic and drug resistance is prevalent, whereas the plant extract derivatives are safe. In the present study, the effect of methanolic and aqueous extracts of Eucalyptus camaldulensis on the promastigotes of Leishmania major was evaluated. The methanolic and aqueous extracts of E. camaldulensis leaves were prepared. The compounds were dried and powdered. Serial dilutions of the extracts and control drugs in phosphate buffer solution were prepared. The stationary phase promastigotes of L. major were incubated to the methanolic and aqueous extractions in vitro. Tartar emetic was used as the positive control drug. After 72 h of incubation the activity of the extracts was measured, using MTT method. The IC50 values (50 % inhibitory concentration) were 586.2 ± 47.6 and 1,108.6 ± 51.9 μg/ml for methanolic and aqueous extracts, respectively, whereas it was 32.5 ± 6.8 μg/ml for tartar emetic. The results indicated that the methanolic extract was more effective than aqueous extract, although there was no significant difference. The extracts were less effective as compared to the control drug. Further investigation is required to evaluate these extracts on clinical stage in macrophage-amastigote model.

Keywords

Eucalyptus camaldulensis Leishmania major Promastigote Herbal medicines 

References

  1. Adraiane L, Nery Zenilda B, de Morais F, Ana Carolina L, Amorim G, da S (2009) Study antileishmania activity of essential oil of Eucalyptus globulus and Eegenia uniflora in Leishmania amazonensis. In: 32 annual meeting of the Brazilian chemical society, Fortaleza, CE, BrazilGoogle Scholar
  2. Ayepola OO, Adeniyi BA (2008) The antibacterial activity of leaf extracts of Eucalyptus camaldulensis (Myrtaceae). J Appl Sci Res 4:1410–1413Google Scholar
  3. Babaee Khou L, Mohebali M, Niakan Lahiji PD, Mehrabi Tavana A (2007) The therapeutic effects of Eucalyptus, Myrtus, Ferula, Aretmisia, Allium and Urtica extracts against cutaneous leishmaniasis caused by Leishmanaia major in small white mice (out-bred). Hakim Res J 10:21–27Google Scholar
  4. Batish DR, Singh HP, Kohli RK, Kaur S (2008) Eucalyptus essential oil as a natural pesticide. For Ecol Manag 256:2166–2174CrossRefGoogle Scholar
  5. Berg K, Zhai L, Chen M, Kharazmi A, Owen TC (1994) The use of a water-soluble formazan complex to quantitate the cell number and mitochondrial function of Leishmania major promastigotes. Parasitol Res 80:235–239CrossRefPubMedGoogle Scholar
  6. Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27:305–318CrossRefPubMedGoogle Scholar
  7. Doroodgar A, Arbabi M, Razavi MR, Mohebali M, Sadr F (2008) Treatment of cutaneous leishmaniasis in murine model by hydro alcoholic essence of Artemisia sieberi. Iran J Arthropod Borne Dis 2:42–47Google Scholar
  8. Hadighi R, Boucher P, Khamesipour A, Meamar AR, Roy G, Ouellette M, Mohebali M (2007) Glucantime-resistant Leishmania tropica isolated from Iranian patient with cutaneous leishmaniasis are sensitive to alterative antileishmania drugs. Parasitol Res 101(5):1319–1322CrossRefPubMedGoogle Scholar
  9. Huber W, Koella JC (1993) A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites. Acta Trop 55(4):257–261CrossRefPubMedGoogle Scholar
  10. Juergens UR, Stober M, Vetter H (1998) Inhibition of cytokine production and arachidonic acid metabolism by eucalyptol (1.8-cineole) in human blood monocytes in vitro. Eur J Med Res 3(11):508–510PubMedGoogle Scholar
  11. Leung AY, Foster S (1996) Encyclopedia of common natural ingredients used in food, drugs, and cosmetics, 2nd edn. Willey, New York, pp 232–233Google Scholar
  12. Mirzaie M, Nosratabadi SJ, Derakhshanfar A, Sharif I (2007) Antileishmanial activity of Peganum harmala extract on the in vitro growth of Leishmania major promastigotes in comparison to a trivalent antimony drug. Vet Arh 77:365–375Google Scholar
  13. Monzote Fidalgo L, Montalvo Alvarez AM, Geigel LF, Perez Pineiro R, Suarez Navarro M, Rodraguez Cabrera H (2004) Effect of thiadiazine derivatives on intracellular amastigotes of Leishmania amazonensis. Mem Ins Oswaldo Cruz Rio de Janeiro 99:329–330CrossRefGoogle Scholar
  14. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63CrossRefPubMedGoogle Scholar
  15. Newall CA, Anderson LA, Phillipson JD (1996) Herbal medicines. A guide for health-care professionals. The Pharmaceutical Press, LondonGoogle Scholar
  16. Pattnaik S, Subramanyam V, Kole C (1996) Antibacterial and antifungal activity of ten essential oils in vitro. Microbios 86:237PubMedGoogle Scholar
  17. Roberts WL, Rainey PM (1993) Antileishmanial activity of sodium stibogluconate fractions. Antimicrob Agents Chemother 37:1842–1846CrossRefPubMedCentralPubMedGoogle Scholar
  18. Sacks DL, Perkins PV (1984) Identification of an infective stage of Leishmania promastigotes. Science 223:1417–1419CrossRefPubMedGoogle Scholar
  19. Sereno D, Holzmuller P, Lemesre JL (2000) Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum. Acta Tropica 74:25–31Google Scholar
  20. Sereno D, Cavaleyra M, Zemzoumi K, Maquaire S, Ouaissi A, Lemesre JL (1998) Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action. Antimicrob Agents Chemother 42:3097–3102PubMedCentralPubMedGoogle Scholar
  21. Sereno D, Guilvard E, Maquaire S, Cavaleyra M, Holzmuller P, Ouaissi A, Lemesre JL (2001) Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: implications for the spread of chemoresistance in endemic areas. Acta Trop 80:195–205CrossRefPubMedGoogle Scholar
  22. Sharma U, Velpandian T, Sharma P, Singh S (2009) Evaluation of anti-leishmanial activity of selected Indian plants known to have antimicrobial properties. Parasitol Res 105:1287–1293CrossRefPubMedGoogle Scholar
  23. Su V, King D, Woodrow I, McFadden G, Gleadow R (2008) Plasmodium falciparum growth is arrested by monoterpenes from eucalyptus oil. Flavour Fragr J 23:315–318CrossRefGoogle Scholar
  24. Verma Sh, Singh SP (2008) Current and future status of herbal medicines. Vet Word 1(11):347–350CrossRefGoogle Scholar
  25. Williams C, Espinosa OA, Montenegro H, Cubilla L, Capson TL, Ortega-Barria E, Romero LI (2003) Hydrosoluble formazan XTT: its application to natural products drug discovery for Leishmania. J Microbiol Methods 55:813–881CrossRefPubMedGoogle Scholar
  26. World Health Organization (2010) Control of the leishmaniasis. World Health Organ Tech Rep Ser 949:186Google Scholar

Copyright information

© Indian Society for Parasitology 2013

Authors and Affiliations

  • Seyyed Jafar Nosratabadi
    • 1
  • Iraj Sharifi
    • 2
  • Fariba Sharififar
    • 3
  • Mehdi Bamorovat
    • 2
  • Hamid Daneshvar
    • 4
  • Mohammad Mirzaie
    • 5
  1. 1.Islamic Azad UniversityKermanIran
  2. 2.Leishmaniasis Research CenterKerman University of Medical SciencesKermanIran
  3. 3.Faculty of Pharmacy, Herbal and Traditional Medicines Research CenterKerman University of Medical SciencesKermanIran
  4. 4.Immunology DepartmentKerman University of Medical SciencesKermanIran
  5. 5.Pathobiology Department, School of Veterinary MedicineShahid Bahonar University of KermanKermanIran

Personalised recommendations